Maternal Choline as a Methyl Donor: One-Carbon Metabolism, DNA Methylation, and Risk of Neural Tube Defects

Yasmin Hammami Background: Neural tube defects (NTDs) remain a leading cause of neonatal mortality, occurring in 2 per 1,000 births globally and nearly 300,000 cases annually.1 Despite folic acid fortification, 40–50% of NTDs persist, underscoring the insufficiency of folate monotherapy.1,2 Folate-dependent methylation regulates the genes and cellular processes needed for…
Featured Abstracts Metabolism Neuroscience

Treatments for Neuropathology Induced by Branched-Chain Amino Acids in Maple Syrup Urine Disease

Josh Botros  Background: Maple syrup urine disease (MSUD) is an autosomal recessive metabolic disorder caused by a deficiency of the branched-chain α-keto acid dehydrogenase (BCKD) complex, resulting in the accumulation of branched-chain amino acids (BCAAs).1 Current primary treatment through dietary restriction or liver transplantation improves survival but does not fully…
Featured Abstracts Metabolism Neuroscience

Isocitrate Dehydrogenase Enzyme Mutations in Glioblastoma Multiforme Metabolism and Cell Survival

Daniel Connors Introduction. Glioblastoma is an aggressive astrocyte-derived brain cancer with a poor prognosis. Survival in glioblastoma patients is typically prolonged for only a few months with intervention.1 In adult glioblastoma patients, mutations in IDH1/2 genes presage a better overall survival.5 IDH1mt patients have been shown to have longer survival…
Cancer Metabolism

Increased Expression of MOTS-c Due to Physical Activity Improves Glucose Regulation in the Progression of Type 2 Diabetes Mellitus

Audrey Kelley Introduction: Type 2 Diabetes Mellitus (T2DM) is the most common metabolic disease in the world, and is characterized by an insufficient response to insulin with subsequent glucose accumulation in the blood.1,2 High-fat diets contribute to the development and progression of the disease by downregulating the expression of glucose…
Metabolism